AlphaFold predicted structure
RARS2 · Q5T160

Mean pLDDT
89.1/ 100
Confident
578 residues
Confidence breakdown
- Very high(≥ 90)63%
- Confident(70–90)29%
- Low(50–70)7%
- Very low(< 50)0%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
arginyl-tRNA synthetase 2, mitochondrial
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Ataxia and cerebellar anomalies - narrow panel
BIALLELIC, autosomal or pseudoautosomalCerebellar hypoplasia
BIALLELIC, autosomal or pseudoautosomalDDG2P
BIALLELIC, autosomal or pseudoautosomalEarly onset or syndromic epilepsy
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalHereditary ataxia
BIALLELIC, autosomal or pseudoautosomalHereditary ataxia with onset in adulthood
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomal+6 more panels — install the extension to see the full list inline on any page.
pontocerebellar hypoplasia type 6
pontocerebellar hypoplasia
Non-syndromic pontocerebellar hypoplasia
hereditary disease
epilepsy
mitochondrial disease
inborn mitochondrial metabolism disorder
isolated cerebellar hypoplasia/agenesis
Loss of consciousness
neurodegenerative disease
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Probable arginine--tRNA ligase, mitochondrial
Catalyzes the attachment of arginine to tRNA(Arg) in a two-step reaction: arginine is first activated by ATP to form Arg-AMP and then transferred to the acceptor end of tRNA(Arg)
RARS2 · Q5T160

Mean pLDDT
89.1/ 100
Confident
578 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0